GO:0048146 positive regulation of fibroblast proliferation: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048146 describes any process that activates or increases the frequency, rate or extent of fibroblast multiplication [1,2].
• Fibroblast proliferation is driven by growth factors, cytokines, and extracellular matrix cues that converge on ERK, PI3K/AKT, and PKC signaling [1,2,4].
• Dysregulated positive regulation of fibroblast proliferation underlies fibrosis in skin, lung, heart, and joint tissues [2,4,5,6,7].
• Key molecular players include TGF-β1, ERK1/2, PKC isoforms, galectin-1, FOXF1, SHH, and microRNAs such as miR-21-3p and miR-654-5p [1,2,3,4,5,7,8].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of fibroblast proliferation pathways [2,5,8].
• Therapeutic strategies targeting fibroblast proliferation are being explored for fibrosis, keloids, rheumatoid arthritis, and wound healing [3,4,5,6,7].
Description
Fibroblasts are the principal mesenchymal cells responsible for producing and remodeling the extracellular matrix, and their controlled proliferation is essential for tissue repair and homeostasis [1,3]. The Gene Ontology term GO:0048146, positive regulation of fibroblast proliferation, captures any biological process that activates or increases the frequency, rate, or extent of fibroblast multiplication [1,2]. This term is central to understanding both normal wound healing and pathological fibrotic diseases, where excessive fibroblast proliferation leads to tissue scarring and organ dysfunction [2,4,5]. Research into GO:0048146 has identified multiple signaling pathways, including ERK/MAPK, PI3K/AKT, and protein kinase C (PKC) cascades, that converge to drive fibroblast cell cycle progression [1,2]. Moreover, non-coding RNAs, growth factors, and metabolic cues such as lactate have been shown to modulate this process in diverse contexts, from cutaneous wound healing to cardiac and pulmonary fibrosis [3,4,6,8]. Understanding the molecular regulators of fibroblast proliferation is therefore critical for developing targeted therapies against fibroproliferative disorders [2,5,7].
positive regulation of fibroblast proliferation At A Glance
| GO ID | GO:0048146 |
|---|---|
| GO term | positive regulation of fibroblast proliferation |
| Ontology | biological_process |
| Synonym | activation of fibroblast proliferation, stimulation of fibroblast proliferation, up regulation of fibroblast proliferation, up-regulation of fibroblast proliferation, upregulation of fibroblast proliferation |
| Major function | Increases the frequency, rate or extent of fibroblast multiplication, contributing to tissue repair, remodeling, and fibrosis [1,2,4]. |
| Key signaling pathways | ERK/MAPK, PI3K/AKT, PKC, TGF-β1/Smad [1,2,4,6]. |
| Representative regulators | TGF-β1, ERK1/2, PKC isoforms, galectin-1, FOXF1, SHH, miR-21-3p, miR-654-5p [1,2,3,4,5,7,8]. |
| Associated diseases | Fibrosis (cardiac, pulmonary, skin), keloids, rheumatoid arthritis, impaired wound healing [2,3,4,5,6,7]. |
| Research methods | CRISPR knockout/knock-in, overexpression, RNA-seq, phospho-proteomics, EdU/BrdU proliferation assays [2,5,8]. |
What Is GO:0048146?
GO:0048146, positive regulation of fibroblast proliferation, is defined as any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. In practical terms, it encompasses the signaling events, gene expression changes, and metabolic shifts that push fibroblasts to enter and progress through the cell cycle, leading to an increased number of fibroblasts in a tissue or culture [1,2,4].
Why Is positive regulation of fibroblast proliferation Important in Cell Biology?
Positive regulation of fibroblast proliferation is a double-edged sword: it is indispensable for wound healing and tissue regeneration, but its dysregulation drives fibrosis, a leading cause of organ failure and morbidity worldwide [2,3,4,5]. Elucidating the molecular mechanisms that control this process is essential for identifying therapeutic targets that can promote repair without inducing pathological scarring [2,5,7].
• Critical for normal wound healing and tissue repair after injury.
• Drives pathological fibrosis in heart, lung, skin, and joints [2,4,5,6,7].
• Contributes to keloid formation and hypertrophic scarring.
• Involved in rheumatoid arthritis synovial hyperplasia.
• Modulated by growth factors, cytokines, and metabolic signals [1,4,6].
• Targeted by anti-fibrotic therapies in preclinical models [2,4,5].
• Regulated by non-coding RNAs and epigenetic modifications [3,6,7].
• Provides a paradigm for studying cell cycle control in mesenchymal cells [1,2].
• Relevant to cancer-associated fibroblasts and tumor microenvironment [5,8].
• Enables development of precision CRISPR models for causal gene validation [2,5,8].
What Happens During positive regulation of fibroblast proliferation?
Initiation by Growth Factors and Cytokines
In simple terms: Signals from outside the cell tell fibroblasts to start dividing.
Positive regulation of fibroblast proliferation is typically initiated when growth factors such as TGF-β1, platelet-derived growth factor (PDGF), or fibroblast growth factor (FGF) bind to their receptors on the fibroblast surface [4,6]. This binding activates receptor tyrosine kinases or serine/threonine kinase receptors, leading to downstream phosphorylation cascades. For example, TGF-β1 activates Smad2/3 and also non-canonical pathways including ERK and PI3K/AKT, which promote cell cycle entry [4,6]. In cardiac fibroblasts, classical and novel PKC isoforms differentially regulate proliferation and transdifferentiation, highlighting the complexity of upstream signaling.
Intracellular Signaling Cascades
In simple terms: A relay of proteins inside the cell amplifies the growth signal.
Once activated, receptors recruit adaptor proteins and guanine nucleotide exchange factors that activate RAS, leading to RAF-MEK-ERK cascade activation. ERK translocates to the nucleus and phosphorylates transcription factors such as ELK1, promoting expression of cyclins and other proliferation-associated genes. In human skin fibroblasts, polydeoxyribonucleotide has been shown to modulate ERK activity, indicating that ERK is a key node in fibroblast proliferation regulation. Additionally, the PI3K/AKT pathway promotes survival and proliferation by inhibiting pro-apoptotic proteins and activating mTOR, which drives protein synthesis and cell growth [2,4].
Cell Cycle Entry and Progression
In simple terms: The cell commits to division and copies its DNA.
Sustained ERK and PI3K/AKT signaling induces expression of cyclin D1, which partners with CDK4/6 to phosphorylate RB, releasing E2F transcription factors that drive S-phase entry [1,2]. Cyclin E-CDK2 further phosphorylates RB, ensuring irreversible commitment to the cell cycle. In fibroblasts, this process is tightly regulated by CDK inhibitors such as p21 and p27, which can be downregulated by proliferative signals. The net result is increased DNA synthesis and mitosis, measurable by EdU or BrdU incorporation [3,5].
Modulation by Non-coding RNAs and Epigenetic Factors
In simple terms: Small RNA molecules and chemical tags on DNA can fine-tune proliferation.
MicroRNAs and circular RNAs can either promote or inhibit fibroblast proliferation by targeting key signaling components. For instance, exosomal miR-21-3p from human umbilical cord blood accelerates cutaneous wound healing by promoting fibroblast function, including proliferation. In rheumatoid arthritis, circ_0003972 promotes fibroblast-like synoviocyte proliferation and inflammation via the miR-654-5p/FZD4 axis. Epigenetic modifications, such as H3K18 lactylation, can stimulate the LTBP3/TGF-β1 axis in keloid fibroblasts, linking metabolism to proliferative gene expression.
Integration with Tissue Microenvironment
In simple terms: The surrounding tissue sends additional cues that influence fibroblast division.
Fibroblast proliferation is not cell-autonomous; it is influenced by extracellular matrix stiffness, hypoxia, and inflammatory cytokines. In pulmonary fibrosis, galectin-1 inhibition attenuates lung fibroblast activation and proliferation, suggesting that galectin-1 integrates microenvironmental signals. FOXF1 and SHH participate in iron signaling in pulmonary fibrosis, which may indirectly affect fibroblast proliferation. These interactions highlight the importance of studying GO:0048146 in the context of tissue-specific microenvironments [5,8].
Key Genes Involved in GO:0048146 positive regulation of fibroblast proliferation
The following genes and proteins have been experimentally implicated in the positive regulation of fibroblast proliferation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFB1 | Master cytokine that promotes fibroblast proliferation and myofibroblast differentiation via Smad and non-Smad pathways [4,6]. | Target for anti-fibrotic therapies; knockout and overexpression models available [4,6]. |
| ERK1/2 (MAPK3/MAPK1) | Kinases that transmit mitogenic signals from growth factor receptors to the nucleus. | Phosphorylation status serves as a readout of proliferative signaling. |
| PKC isoforms | Classical and novel PKC isoforms differentially regulate cardiac fibroblast proliferation and transdifferentiation. | Isoform-specific knockout or point mutations can dissect their roles. |
| GALECTIN-1 (LGALS1) | Promotes lung fibroblast activation and proliferation; inhibition attenuates fibrosis. | Knockout or knockdown models for lung fibrosis research. |
| FOXF1 | Transcription factor involved in iron signaling and pulmonary fibrosis. | Knockout models to study its role in fibroblast proliferation. |
| SHH | Sonic hedgehog signaling participates in pulmonary fibrosis and may influence fibroblast proliferation. | Overexpression or knockout models for pathway dissection. |
| MIR21 | Exosomal miR-21-3p promotes angiogenesis and fibroblast function in wound healing. | Mimic or inhibitor studies in cutaneous wound models. |
| MIR654 | Targeted by circ_0003972; regulates FZD4 and fibroblast-like synoviocyte proliferation. | Knockdown or overexpression in rheumatoid arthritis models. |
| FZD4 | Wnt receptor that mediates proliferative signals in synovial fibroblasts. | Knockout or point mutation to study Wnt signaling. |
| CIRC_0003972 | Circular RNA that sponges miR-654-5p to promote FZD4 expression and proliferation. | Overexpression or knockdown in arthritis research. |
| LTBP3 | Latent TGF-β binding protein 3; mediates lactate-induced TGF-β1 activation in keloid fibroblasts. | Knockout or knock-in to study metabolic regulation. |
| H3K18 lactylation | Epigenetic mark that stimulates LTBP3/TGF-β1 axis in keloid fibroblasts. | Point mutations in histone or metabolic enzymes. |
| PDGF | Growth factor that stimulates fibroblast proliferation via receptor tyrosine kinases. | Exogenous treatment or receptor knockout models. |
| FGF | Fibroblast growth factor family members promote proliferation in various fibroblast types. | Overexpression or ligand-blocking studies. |
| IL-6 | Inflammatory cytokine that can indirectly promote fibroblast proliferation. | Knockout or neutralizing antibody models. |
| MMP9 | Matrix metalloproteinase involved in ECM remodeling and fibroblast activation. | Knockout models to study fibrosis. |
| COL1A1 | Major collagen produced by proliferating fibroblasts; marker of activation. | Reporter knock-in for live imaging. |
| ACTA2 | Alpha-smooth muscle actin; marks myofibroblast transdifferentiation. | Tagged knock-in for lineage tracing. |
How Is positive regulation of fibroblast proliferation Regulated?
Positive regulation of fibroblast proliferation is controlled by a multilayered regulatory network. At the receptor level, growth factor availability and receptor expression levels determine the strength and duration of proliferative signals [4,6]. Intracellularly, negative feedback loops involving MAPK phosphatases and CDK inhibitors restrain excessive proliferation [1,2]. Non-coding RNAs, including microRNAs and circular RNAs, fine-tune the expression of key signaling components; for example, miR-21-3p promotes fibroblast function in wound healing, while circ_0003972 sponges miR-654-5p to enhance FZD4 expression and proliferation in rheumatoid arthritis [3,7]. Epigenetic modifications, such as H3K18 lactylation, link metabolic state to proliferative gene expression in keloid fibroblasts. Additionally, protein kinase C isoforms differentially regulate cardiac fibroblast proliferation, with classical and novel isoforms exerting distinct effects. These regulatory mechanisms ensure that fibroblast proliferation is appropriately balanced during tissue repair but can become dysregulated in fibrosis [2,5].
positive regulation of fibroblast proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFB1 | Cardiac fibrosis, keloids | Knockout or overexpression in cardiac/skin fibroblasts [4,6] |
| PKC isoforms | Cardiac fibrosis | Isoform-specific knockout or point mutations |
| LGALS1 | Pulmonary fibrosis | Knockout or knockdown in lung fibroblasts |
| CIRC_0003972 | Rheumatoid arthritis | Overexpression or knockdown in synoviocytes |
| FOXF1/SHH | Pulmonary fibrosis | Knockout or overexpression in lung fibroblasts |
Fibrosis and Fibroproliferative Disorders
Excessive positive regulation of fibroblast proliferation is a hallmark of fibrosis in multiple organs. In cardiac fibrosis, PKC isoforms differentially regulate fibroblast proliferation and transdifferentiation, suggesting that isoform-selective inhibitors could be therapeutic. In pulmonary fibrosis, galectin-1 inhibition attenuates lung fibroblast activation and proliferation, and FOXF1/SHH signaling participates in iron signaling linked to fibrosis [5,8]. In skin, lactate promotes collagen expression and proliferation in keloid fibroblasts via H3K18 lactylation-dependent LTBP3/TGF-β1 axis, identifying a metabolic target for keloid therapy.
Rheumatoid Arthritis
In rheumatoid arthritis, fibroblast-like synoviocytes undergo excessive proliferation, contributing to synovial hyperplasia and joint destruction. Circ_0003972 promotes proliferation and inflammation of fibroblast-like synoviocytes through regulation of the miR-654-5p/FZD4 axis, highlighting a potential therapeutic target.
Impaired Wound Healing
Conversely, insufficient fibroblast proliferation can impair wound healing. Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function, including proliferation. This suggests that enhancing fibroblast proliferation in a controlled manner could benefit chronic wounds.
From positive regulation of fibroblast proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce fibroblast proliferation? | CRISPR knockout in primary fibroblasts or cell lines [2,5] |
| Does a specific point mutation in a kinase alter proliferative signaling? | CRISPR point mutation knock-in |
| Does overexpression of a growth factor drive proliferation? | CRISPR-mediated overexpression or lentiviral transduction [4,6] |
| Can we track fibroblast proliferation in real time? | Tagged knock-in of fluorescent reporter (e.g., PCNA-GFP) |
| What is the role of a non-coding RNA in proliferation? | CRISPR knockout of the RNA locus or overexpression |
| Does a metabolic enzyme regulate proliferation via epigenetic marks? | Knockout or point mutation of the enzyme |
How to Study the positive regulation of fibroblast proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU/BrdU incorporation | DNA synthesis (S-phase entry) | Quantifying fibroblast proliferation after gene knockout [3,5] |
| Phospho-ERK Western blot | ERK pathway activation | Assessing signaling after growth factor stimulation |
| RNA-seq | Global gene expression changes | Identifying proliferation-associated transcriptional programs [6,7] |
| ChIP-seq for H3K18 lactylation | Epigenetic mark enrichment | Linking metabolism to proliferative gene expression |
| CRISPR knockout screen | Gene essentiality for proliferation | Discovering novel regulators of fibroblast proliferation [2,5] |
| Immunofluorescence for Ki-67 | Cells in active cell cycle | Visualizing proliferation in tissue sections |
| Cell migration assay | Migratory capacity | Assessing functional consequences of proliferation changes |
| ELISA for TGF-β1 | Cytokine secretion | Measuring autocrine proliferative signals [4,6] |
Proliferation Assays
Direct measurement of fibroblast proliferation is typically performed using EdU or BrdU incorporation, which labels newly synthesized DNA in S-phase cells [3,5]. Alternatively, cell counting or MTT assays provide population-level proliferation rates. These assays are essential for validating the effects of genetic perturbations on GO:0048146 [2,5].
Signaling Pathway Analysis
Phospho-specific antibodies and Western blotting are used to assess activation of ERK, AKT, and PKC pathways following stimulation or genetic manipulation [1,2]. For example, polydeoxyribonucleotide modulates ERK activity in human skin fibroblasts, demonstrating the utility of phospho-ERK as a readout. Kinase activity assays can further confirm specific isoform contributions.
Transcriptomic and Epigenomic Profiling
RNA-seq can identify global gene expression changes associated with increased fibroblast proliferation, including cyclins and ECM components [6,7]. ATAC-seq or ChIP-seq for histone modifications such as H3K18 lactylation can reveal epigenetic mechanisms driving proliferative gene programs. These methods help uncover novel regulators of GO:0048146.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens can systematically identify genes that positively or negatively regulate fibroblast proliferation [2,5]. Such screens are powerful for discovering new therapeutic targets in fibrosis and cancer-associated fibroblasts. Validation of hits is typically performed with individual knockouts and proliferation assays [5,8].
How CRISPR Can Be Used to Study GO:0048146 positive regulation of fibroblast proliferation
Knockout
CRISPR knockout of candidate genes such as LGALS1 or PKC isoforms allows researchers to determine whether the gene is required for positive regulation of fibroblast proliferation [2,5]. For example, knockout of galectin-1 attenuates lung fibroblast activation and proliferation, validating its role in pulmonary fibrosis. Knockout models are also used to confirm hits from CRISPR screens.
Point Mutation
Point mutations can be introduced to study specific phosphorylation sites or catalytic residues in kinases like ERK or PKC, revealing their precise contribution to fibroblast proliferation [1,2]. For instance, mutating a key phosphorylation site in PKC isoforms can distinguish their differential effects on proliferation and transdifferentiation.
Knock-in
Knock-in of reporter genes, such as fluorescent proteins under the control of proliferation markers, enables live tracking of fibroblast proliferation. Tagged knock-in of ECM proteins like COL1A1 can also report on fibroblast activation state. These models are valuable for high-content imaging and lineage tracing.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive high-level expression of growth factors or non-coding RNAs to test sufficiency for promoting fibroblast proliferation [4,6,7]. For example, overexpression of circ_0003972 promotes synoviocyte proliferation, confirming its role in rheumatoid arthritis.
How EDITGENE Supports positive regulation of fibroblast proliferation Research
Researchers studying positive regulation of fibroblast proliferation-related genes often need to determine whether a candidate gene is causally involved in driving or restraining fibroblast multiplication. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of fibroblast proliferation research.
Frequently Asked Questions About positive regulation of fibroblast proliferation
What is GO:0048146?
GO:0048146 is the Gene Ontology term for positive regulation of fibroblast proliferation, defined as any process that activates or increases the frequency, rate or extent of fibroblast multiplication [1,2].
What genes are involved in positive regulation of fibroblast proliferation?
Key genes include TGFB1, ERK1/2, PKC isoforms, LGALS1, FOXF1, SHH, MIR21, MIR654, FZD4, and CIRC_0003972, among others [1,2,3,4,5,7,8].
How is fibroblast proliferation measured in the lab?
Common methods include EdU/BrdU incorporation, Ki-67 immunofluorescence, cell counting, and MTT assays [3,5].
What signaling pathways regulate fibroblast proliferation?
Major pathways are ERK/MAPK, PI3K/AKT, PKC, and TGF-β1/Smad [1,2,4,6].
What diseases involve excessive fibroblast proliferation?
Fibrosis (cardiac, pulmonary, skin), keloids, and rheumatoid arthritis are associated with dysregulated fibroblast proliferation [2,4,5,6,7].
Can CRISPR be used to study fibroblast proliferation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in fibroblast proliferation [2,5,8].
What is the role of TGF-β1 in fibroblast proliferation?
TGF-β1 is a master cytokine that promotes fibroblast proliferation and myofibroblast differentiation through Smad and non-Smad pathways [4,6].
How do non-coding RNAs affect fibroblast proliferation?
MicroRNAs and circular RNAs can sponge or target signaling components; for example, miR-21-3p promotes wound healing, while circ_0003972 enhances synoviocyte proliferation [3,7].
What is the link between metabolism and fibroblast proliferation?
Lactate can promote collagen expression and proliferation via H3K18 lactylation-dependent LTBP3/TGF-β1 axis in keloid fibroblasts.
How can I create a knockout of a gene involved in fibroblast proliferation?
EDITGENE provides custom CRISPR knockout services for fibroblast cell models, ensuring validated gene editing and functional readouts [2,5].
Conclusion
GO:0048146, positive regulation of fibroblast proliferation, is a fundamental biological process with broad implications for tissue repair and fibrotic disease. The integration of growth factor signaling, intracellular kinases, non-coding RNAs, and epigenetic modifications creates a complex regulatory network that is now amenable to precise CRISPR-based dissection. Understanding these mechanisms will accelerate the development of targeted therapies for fibrosis, keloids, rheumatoid arthritis, and impaired wound healing.
References
- 1. Shin SM et al.. 2023. Polydeoxyribonucleotide exerts opposing effects on ERK activity in human skin keratinocytes and fibroblasts.. Mol Med Rep 28(2) PMID: 37350391
- 2. Karhu ST et al.. 2021. Distinct Regulation of Cardiac Fibroblast Proliferation and Transdifferentiation by Classical and Novel Protein Kinase C Isoforms: Possible Implications for New Antifibrotic Therapies.. Mol Pharmacol 99(2):104-113 PMID: 33239332
- 3. Hu Y et al.. 2018. Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function.. Theranostics 8(1):169-184 PMID: 29290800
- 4. Zhao L et al.. 2016. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition.. Eur J Pharmacol 783:33-46 PMID: 27108788
- 5. Xue J et al.. 2023. Inhibition of Galectin-1 attenuates lung fibroblast activation and proliferation in lung fibrosis.. Cell Mol Biol (Noisy-le-grand) 69(11):213-218 PMID: 38015516
- 6. Gu JJ et al.. 2026. Lactate Promotes Collagen Expression, Proliferation, and Migration through H3K18 Lactylation-Dependent Stimulation of LTBP3/TGF-β1 Axis in Keloid Fibroblasts.. J Invest Dermatol 146(2):522-534.e8 PMID: 40633755
- 7. Li J et al.. 2022. Circ_0003972 Promotes the Proliferation and Inflammation of Fibroblast-like Synovial Cells in Rheumatoid Arthritis through Regulation of the miR-654-5p/FZD4 Axis.. Immunol Invest 51(5):1437-1451 PMID: 34325604
- 8. Wang X et al.. 2025. FOXF1 and SHH participate in the regulation of iron signaling in pulmonary fibrosis.. Redox Biol 87:103893 PMID: 41101211
